PPGN (PPGN) News
Follow PPGN (PPGN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 9 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Polypeptide board recommends shareholders accept Samsung offer
Polypeptide board recommends shareholders accept a Samsung offer.
EQUITY | Aug 31, 2026, 05:05 AM UTC
L
Samsung Biologics publishes PolyPeptide tender offer prospectus
Samsung Biologics has published a prospectus for PolyPeptide’s public tender offer.
EQUITY | Aug 31, 2026, 05:00 AM UTC
L
Samsung Peptide launches tender offer for Polypeptide
Samsung Peptide has launched a tender offer for Polypeptide.
EQUITY | Aug 31, 2026, 04:58 AM UTC
L
Samsung Biologics to List New Shares in November
Samsung Biologics to List New Shares in November
EQUITY | Aug 27, 2026, 11:48 PM UTC
L
Proceeds plan: stake purchase and facility investment
Samsung Biologics will use proceeds for a stake purchase and facility investment.
EQUITY | Aug 27, 2026, 11:47 PM UTC
M
Samsung Biologics to issue about 2.3M shares at KRW1,322,000 each
Samsung Biologics plans to issue about 2.3M shares at KRW1,322,000 each.
EQUITY | Aug 27, 2026, 11:46 PM UTC
M
Samsung Biologics to raise about KRW 3T via rights issue
Samsung Biologics plans to raise about KRW 3T through a rights issue.
EQUITY | Aug 27, 2026, 11:46 PM UTC
M
Samsung Biologics to acquire PolyPeptide Group for KRW2.706T
Samsung Biologics plans to acquire 100% of PolyPeptide Group for KRW2.706T.
MNA | Aug 27, 2026, 11:44 PM UTC
M
Samsung Biologics to buy Swiss contract development and manufacturing organization
Samsung Biologics plans to buy a Swiss contract development and manufacturing organization.
EQUITY | Aug 27, 2026, 11:43 PM UTC